ClinicalTrials.Veeva

Menu

Focal Prostate Ablation Versus Radical Prostatectomy (FARP)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Completed

Conditions

Prostate Cancer

Treatments

Device: Focal HIFU treatment using Focal One (EDAP TMS) or TULSA-PRO (Profound Medical)
Procedure: Radical prostatectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03668652
2017/703

Details and patient eligibility

About

This study aims to compare the treatment results of HIFU and Radical prostatectomy.

Full description

The FARP randomized control study will compare focal ablation of prostate using High Intensity Focused Ultrasound (HIFU) applied by FocalOne® or TULSA® device versus Radical Prostatectomy (RP) in patients with unilateral, intermediate risk prostate cancer.

Enrollment

213 patients

Sex

Male

Ages

45 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Positive MRI (PIRAD 3-5) and biopsy proven unilateral prostate cancer classified as ISUP 1 (with cancer core length > 5mm) or ISUP 2-3 (any length) not eligible to active surveillance or watchful waiting
  • PSA ≤ 20 ng/ml
  • Treatment naive patients with localized prostate cancer (stage ≤ T2b)

Exclusion criteria

  • Clinical stage T> 2b
  • Metastatic lymph node on imaging
  • Patients already treated for Pca (hormone therapy, EBRT)
  • Patients with contra-indications to MRI
  • Patients with active inflammatory bowel disease or previous rectal fistula
  • History of previous pelvic radiotherapy
  • History of bladder cancer
  • History of bladder neck or urethral stricture
  • Urogenital infection in progress
  • Allergy to latex or gadolinium
  • Patients on life support or suffering form unstable neurological diseases

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

213 participants in 2 patient groups

Focal prostate cancer treatment by HIFU
Experimental group
Description:
Patients with target lesion distance \< 30 mm from the rectum will be treated with High Intensity Focused Ultrasound (HIFU) applied by FocalOne HIFU device and patients with lesion localized \> 30 mm from the rectum will be treated with TULSA applied by TULSA-PRO device.
Treatment:
Device: Focal HIFU treatment using Focal One (EDAP TMS) or TULSA-PRO (Profound Medical)
Radical Prostatectomy
Active Comparator group
Description:
Robot assisted laparoscopic radical prostatectomy or open retro-pubic radical prostatectomy will be performed using validated radical prostatectomy technique. Nerve sparing surgery on side of cancer free prostate lobe will be performed and type of nerve sparing procedure will be specified.
Treatment:
Procedure: Radical prostatectomy

Trial contacts and locations

1

Loading...

Central trial contact

Anne Klara Sørbø, nurse

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems